Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
19.03. | Cell MedX Corp. Closes Private Placement Financing | 178 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
19.03. | Cell MedX Corp. - 8-K, Current Report | 2 | SEC Filings | ||
28.02. | Cell MedX Corp. Announces Resignation of Director | 250 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 28, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
28.02. | Cell MedX Corp. - 8-K, Current Report | 2 | SEC Filings | ||
26.02. | Cell MedX names George Adams as chairman of the board | 1 | Seeking Alpha | ||
26.02. | Cell MedX Corp. Appoints Dr. George Adams as Chairman of the Board | 205 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - February 26, 2024) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX", or the "Company") a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
16.01. | Cell MedX Corp. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
19.12.23 | Cell MedX Corp. - 8-K, Current Report | 1 | SEC Filings | ||
19.12.23 | Cell MedX Corp. Announces New CEO and Directors and Debt Settlement | 143 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - December 19, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
27.11.23 | Cell MedX Corp. - 8-K, Current Report | 1 | SEC Filings | ||
27.11.23 | Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order | 251 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 27, 2023) - Cell MedX Corp. ("Cell MedX" or the "Company") (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities... ► Artikel lesen | |
13.11.23 | Cell MedX Corp. - 8-K, Current Report | - | SEC Filings | ||
09.11.23 | Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer | 187 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - November 9, 2023) - Cell MedX Corp. (OTC Pink: CMXC) ("Cell MedX" or the "Company"), a biotech company focusing on the discovery, development and commercialization... ► Artikel lesen | |
16.10.23 | Cell MedX Corp. - 10-Q, Quarterly Report | 1 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SERNOVA | 0,382 | +2,36 % | Sernova gibt Entwicklungen im Management bekannt | London, Ontario und Boston, Massachusetts, den 11. März 2024 - Sernova Corp. (TSX: SVA) (OTCQB: SEOVF) (FWB/XETRA: PSH), ein in der klinischen Phase befindliches Unternehmen, das sich auf
die... ► Artikel lesen | |
VITA 34 | 4,980 | +6,87 % | Biotech Report: Vita34 klettern kräftig, Evotec und Biontech leichter | (shareribs.com) Frankfurt / New York 15.03.2024 - Biotech-Aktien haben sich am Freitag überwiegend leichter präsentiert. Im deutschen Handel verloren unter anderem Evotec deutlich. Auch an der Wall... ► Artikel lesen | |
GERATHERM MEDICAL | 4,320 | -0,46 % | Geratherm Medical AG: Geratherm meldet Kurzarbeit an; Kursziel gesenkt; mwb research bekräftigt KAUFEN | Geratherm hat angekündigt, im Werk Geratal Kurzarbeit zu beantragen, weil der Absatz von Fieberthermometern aufgrund des milden Winters unter Plan lag. Der Anteil der Fieberthermometer am Gesamtumsatz... ► Artikel lesen | |
PLUS THERAPEUTICS | 1,676 | -0,48 % | Plus Therapeutics Inc.: Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights | Began enrollment of the 5th of an anticipated 7 planned dosing cohorts for the ReSPECT-LM Phase 1 dose escalation trial with rhenium (186Re) obisbemeda for leptomeningeal metastases (LM) Reached agreement... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 1,706 | +4,28 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient | SEATTLE, March 19, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), today announced that the pre-menopausal, Estrogen Receptor positive (ER+) / Human... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023 | -- Third Consecutive Year of Phexxi Net Sales Growth --
-- Total Operating Expense Reduced 64% from 2022 Levels --
-- Sales and marketing expense as a percentage of net sales was 54% for the fourth... ► Artikel lesen | |
MEDICLIN | 2,540 | -0,78 % | EQS-News: MediClin AG: MEDICLIN plant Kauf von Reha-Klinik am Sendesaal | EQS-News: MediClin AG
/ Schlagwort(e): Sonstiges
MEDICLIN plant Kauf von Reha-Klinik am Sendesaal
22.03.2024 / 10:04 CET/CEST
Für den Inhalt der Mitteilung ist der Emittent... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 0,179 | +16,23 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Present at Trickle Research and LD Micro Investor Conferences | BOULDER, CO / ACCESSWIRE / March 28, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
NOVACCESS GLOBAL | - | - | NovAccess Global Inc.: NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders | CLEVELAND, OH / ACCESSWIRE / March 1, 2024 / NovAccess Global Inc. (OTCQB:XSNX), a biomedical company developing novel immunotherapies for brain tumor patients, today provided an update on business... ► Artikel lesen | |
REWALK ROBOTICS | 4,590 | -4,28 % | ReWalk Robotics Ltd. (DBA Lifeward): VA STAND Act introduced in the United States Senate | ||
VERU | 0,709 | +7,76 % | Veru Inc.: Veru Reschedules Annual Meeting of Shareholders | ||
MAVEN BRANDS | 0,001 | 0,00 % | XFRA TLA: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILMAVEN BRANDS INC.... ► Artikel lesen | |
EKSO BIONICS | 1,372 | +8,37 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Reports Record Annual Revenue of $18.3 Million | Sold Record Number of Annual EksoHealth Units in 2023 SAN RAFAEL, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 56,72 | +0,60 % | Kurs der Siemens Healthineers-Aktie verharrt auf Vortags-Niveau (55,06 €) | Wenig Kursbewegung zur Stunde bei der Siemens Healthineers-Aktie . Der jüngste Kurs betrug 55,06 Euro. Ein geringes Minus von 0,36 Prozent zeigt die Kurstafel für die Aktie von Siemens Healthineers... ► Artikel lesen | |
FRESENIUS | 25,000 | +0,20 % | Fresenius-Aktie kann Vortagsniveau nicht halten (24,57 €) | Im deutschen Wertpapierhandel notiert das Wertpapier von Fresenius zur Stunde etwas leichter. Die Aktie kostete zuletzt 24,57 Euro. Für Inhaber von Fresenius ist der heutige Handelstag bisher nicht... ► Artikel lesen |